glucuronic acid has been researched along with HIV Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshy, KS; Laly, AP; Nandakumar, K; Sabu, T; Snigdha, S; Susan, MA | 1 |
| Bhowmik, BB; Ghosal, K; Ranjan, A | 1 |
| Fong, K; Smith, TJ | 1 |
3 other study(ies) available for glucuronic acid and HIV Infections
| Article | Year |
|---|---|
Encapsulation of zidovudine in PF-68 coated alginate conjugate nanoparticles for anti-HIV drug delivery.
Topics: Alginates; Amides; Anti-HIV Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; HIV; HIV Infections; Humans; Nanoparticles; Zidovudine | 2018 |
A novel vaginal drug delivery system: anti-HIV bioadhesive film containing abacavir.
Topics: Acquired Immunodeficiency Syndrome; Alginates; Animals; Anti-HIV Agents; Chromatography, High Pressure Liquid; Dideoxynucleosides; Drug Delivery Systems; Female; Glucuronic Acid; Glycerol; Hexuronic Acids; HIV Infections; Humans; Hydrogen-Ion Concentration; Hypromellose Derivatives; Kinetics; Materials Testing; Microscopy, Electron, Scanning; Rabbits; Spectroscopy, Fourier Transform Infrared; Stress, Mechanical; Tensile Strength; Vagina | 2014 |
Citrate-mediated release of aurintricarboxylic acid from a calcium alginate complex: implications for intravaginal HIV chemoprophylaxis and related applications.
Topics: Administration, Intravaginal; Alginates; Anti-HIV Agents; Aurintricarboxylic Acid; Chemistry, Pharmaceutical; Citrates; Drug Carriers; Glucuronic Acid; Hexuronic Acids; HIV Infections; Sodium Citrate; Solubility | 2009 |